Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 4
1978 3
1979 3
1981 2
1982 2
1983 5
1984 6
1986 2
1987 6
1988 7
1989 3
1990 5
1991 10
1992 4
1993 10
1994 13
1995 12
1996 4
1997 12
1998 5
1999 8
2000 9
2001 6
2002 8
2003 7
2004 8
2005 16
2006 9
2007 6
2008 11
2009 14
2010 7
2011 13
2012 12
2013 10
2014 16
2015 21
2016 18
2017 21
2018 20
2019 15
2020 22
2021 16
2022 17
2023 12
2024 13
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

PubMed for id: 57571

431 results

Results by year

Filters applied: . Clear all
Page 1
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial.
Fürstenau M, Giza A, Weiss J, Kleinert F, Robrecht S, Franzen F, Stumpf J, Langerbeins P, Al-Sawaf O, Simon F, Fink AM, Schneider C, Tausch E, Schetelig J, Dreger P, Böttcher S, Fischer K, Kreuzer KA, Ritgen M, Schilhabel A, Brüggemann M, Stilgenbauer S, Eichhorst B, Hallek M, Cramer P. Fürstenau M, et al. Blood. 2024 Jul 18;144(3):272-282. doi: 10.1182/blood.2023022730. Blood. 2024. PMID: 38620072 Clinical Trial.
431 results